| | ||||||||||
| 1 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| SORAFENIB
| SORAFENIB | ANTICANCER AGENTS | ORAL | Tmax 3 HOUR F 43.5 PERCENT PPB 99.5 PERCENT HT 36.5 HOUR SOLUBILITY PRACTICALLY INSOLUBLE IN WATER | CRAF BRAF MUTANT BRAF KIT FLT-3 RET VEGFR-1 VEGFR-2 VEGFR-3 PDGFR-BETA PDB 1UWJ (THE COMPLEX OF MUTANT V599E B-RAF AND BAY439006.) LIGAND CODE = BAX (link to the list of PDB complexes) Download experimental 3D coordinates of BAX with added hydrogens | SERINE/THREONINE-PROTEIN KINASE RAF INHIBITOR CHEMBL1906 SERINE/THREONINE-PROTEIN KINASE RAF P04049 RAF PROTO-ONCOGENE SERINE/THREONINE-PROTEIN KINASE HOMO SAPIENS ENZYME KINASE PROTEIN KINASE TKL RAF | EMA | |||
